TY  - JOUR
AU  - Chaparro, Maria
AU  - Gordillo, Jordi
AU  - Domenech, Eugeni
AU  - Esteve, Maria
AU  - Barreiro-de Acosta, Manuel
AU  - Villoria, Albert
AU  - Iglesias-Flores, Eva
AU  - Blasi, Mercedes
AU  - Naves, Juan E
AU  - Benítez, Olga
AU  - Nieto, Laura
AU  - Calvet, Xavier
AU  - Garcia-Sanchez, Valle
AU  - Villagrasa, Jose Ramon
AU  - Marin, Alicia C
AU  - Donday, Maria G
AU  - Abad-Santos, Francisco
AU  - Gisbert, Javier P
PY  - 2020
DO  - 10.14309/ajg.0000000000000926
UR  - http://hdl.handle.net/10668/16562
T2  - The American journal of gastroenterology
AB  - To compare Engerix-B and Fendrix hepatitis B virus for primo vaccination in inflammatory bowel disease (IBD). Patients with IBD were randomized 1:1 to receive Engerix-B double dose or Fendrix single dose at months 0, 1, 2, and 6. Anti-HBs titers were...
LA  - en
PB  - Wolters Kluwer Health
KW  - Adrenal cortex hormones
KW  - Drug therapy, combination
KW  - Hepatitis B
KW  - Hepatitis B antibodies
KW  - Hepatitis B vaccines
KW  - Humans
KW  - Immunogenicity, vaccine
KW  - Immunosuppressive agents
KW  - Inflammatory bowel diseases
KW  - Male
KW  - Middle aged
KW  - Tumor necrosis factor inhibitors
TI  - Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial.
TY  - research article
VL  - 115
ER  -